Trial intelligence / Profile preview

Thiophenorphine vs buprenorphine for opioid dependence relapse prevention

CTR20170446Phase 2Active

Sponsor
Beijing Ziduhongye Technology Development
Start
Jul 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of thienorphine in opioid use disorder (OUD), sponsored by Beijing Ziduhongye Technology Development. Started Jul 2017; status: active.

02

Drugs

thienorphine
03

Conditions

opioid use disorder (OUD)

Beyond the preview

Go deeper on CTR20170446.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20170446.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call